LLYEli Lilly and Company Stock Analysis

Exchange: NYSE | Sector: Healthcare | Industry: Drug Manufacturers - General

Current Price: $925.95 (-1.03% today)

Market Cap: $883.99B

P/E (TTM): 40.70

Forward P/E (FY1): 26.90

EPS Growth: 22%

Analyst Upside: 37.3%

Relative Strength (RS%): 14

-18.3% from 52-week high

Back to Scanner

LLY

NYSERS 14Score 39

Eli Lilly and Company

HealthcareDrug Manufacturers - General$883.99B3 setups passing
$925.95
-1.0% ($9.59)
-18.3% from 52W High
P/E (TTM)
40.70
Fwd P/E
26.90
PEG
0.54
Analyst Upside
+37.3%
EPS Growth
22%
Gross Margin
83.8%
ROE
97.9%
D/E
1.60
Div Yield
0.7%
Avg Volume
2.7M

Price Chart

Key Levels

SMA 200
$897.28
SMA 50
$1,000.20
Price
$925.95
52W High
$1,133.35
Target
$1,271.54

Setup Radar

3/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst